HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biphasic changes in angiopoietin-like 8 level after laparoscopic sleeve gastrectomy and type 2 diabetes remission during a 1-year follow-up.

AbstractBACKGROUND:
Angiopoietin-like 8 (ANGPTL8) a hepatic protein, is implicated by several studies with a role in promoting pancreatic β-cell proliferation and improving glucose tolerance. Although a matter of controversy, a growing number of reports support ANGPTL8's potential, yet unclear, role in type 2 diabetes (T2D).
OBJECTIVES:
To examine changes in fasting ANGPTL8 level in people with morbid obesity, with or without diabetes after laparoscopic sleeve gastrectomy (LSG) in a 1-year prospective study.
SETTING:
Dasman Diabetes Institute, government, and private hospitals, Kuwait.
METHODS:
Fasting serum ANGPTL8 was measured by enzyme-linked immunosorbent assay at baseline in participants with morbid obesity, 17 with diabetes and 23 without diabetes, and in healthy weight participants, 19 with and 15 without diabetes, during 1 year post-LSG in participants with morbid obesity.
RESULTS:
At baseline, people with T2D had higher ANGPTL8 level, (morbid obese, mean ± standard error of the mean; 1415 ± 196.4 pg/mL, and healthy weight, 2231 ± 328.1 pg/mL), compared with individuals without T2D (morbid obese, 876 ± 155.0 pg/mL, and healthy weight controls 868.9 ± 218.7 pg/mL). In participants with diabetes and morbid obesity, T2D remission occurred 15 days post-LSG, defined by a sustained reduced fasting blood glucose levels <6.9 mmol/L. In this group, the 1-year post-LSG measurement of ANGPTL8 showed unique biphasic changes, first a prominent elevation (day 60, 3336 ± 916.5 pg/mL, P < .01), followed by a gradual decrease to reach almost the baseline level (day 360, 1184 ± 119.3 pg/mL).
CONCLUSION:
Elevated baseline ANGPTL8 in participants with diabetes at baseline reflected a link to T2D. Interestingly, the unique biphasic pattern of change in fasting ANGPTL8 post-LSG, occurred only in people with diabetes, suggesting ANGPTL8's potential role in T2D remission.
AuthorsEman Al-Shawaf, Ebaa Al-Ozairi, Fahad Al-Asfar, Shaima Al-Beloushi, Surbhi Kumari, Jaakko Tuomilehto, Hossein Arefanian
JournalSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (Surg Obes Relat Dis) Vol. 14 Issue 9 Pg. 1284-1294 (Sep 2018) ISSN: 1878-7533 [Electronic] United States
PMID30054251 (Publication Type: Journal Article)
CopyrightCopyright © 2018 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
Chemical References
  • ANGPTL8 protein, human
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins
  • Peptide Hormones
Topics
  • Adult
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins (blood)
  • Diabetes Mellitus, Type 2 (complications, epidemiology, physiopathology)
  • Female
  • Follow-Up Studies
  • Gastrectomy
  • Humans
  • Laparoscopy
  • Male
  • Obesity, Morbid (blood, complications, epidemiology, surgery)
  • Peptide Hormones (blood)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: